EAM
Eventide Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,116,837
| Closed | -$16.4M | – | 159 |
|
|
2023
Q4 | $16.4M | Hold |
1,116,837
| – | – | 0.27% | 97 |
|
|
2023
Q3 | $20.4M | Hold |
1,116,837
| – | – | 0.37% | 81 |
|
|
2023
Q2 | $24.1M | Buy |
1,116,837
+658,783
| +144% | +$14.2M | 0.41% | 76 |
|
|
2023
Q1 | $13.4M | Buy |
458,054
+208,054
| +83% | +$6.1M | 0.25% | 109 |
|
|
2022
Q4 | $9.24M | Buy |
+250,000
| New | +$9.24M | 0.18% | 110 |
|